atorvastatin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowiak, A; Błoński, JZ; Cebula-Obrzut, B; Hikisz, P; Kiliańska, ZM; Robak, T; Smolewski, P; Żołnierczyk, JD | 1 |
| Bolaman, Z; Kadikoylu, G; Karul, A; Sargin, G; Yavasoglu, I | 1 |
2 other study(ies) available for atorvastatin and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Promising anti-leukemic activity of atorvastatin.
Topics: Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Atorvastatin; bcl-2-Associated X Protein; Cell Membrane Permeability; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; DNA Fragmentation; Female; Heptanoic Acids; Humans; Lamin B Receptor; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Mitochondrial Membranes; Myeloid Cell Leukemia Sequence 1 Protein; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Receptors, Cytoplasmic and Nuclear | 2013 |
The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro.
Topics: ADP-ribosyl Cyclase 1; Annexin A5; Apoptosis; Atorvastatin; Calcium; CD5 Antigens; Female; Heptanoic Acids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphocytes; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Rosiglitazone; Thiazolidinediones; ZAP-70 Protein-Tyrosine Kinase | 2013 |